No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
Established in 1998 and headquartered in New Taipei City, Taiwan, TaiDoc Technology Corporation develops and globally distributes a wide array of medical devices. Their offerings encompass in vitro diagnostics, such as advanced blood glucose and multi-parameter monitoring systems, point-of-care testing equipment, and lancet devices, alongside specialized veterinary health products like blood glucose, calcium, and ketone meters for animals. The company also manufactures general medical equipment, including nebulizers, thermometers, blood pressure and vital sign monitors, and pulse oximeters. Additionally, TaiDoc provides remote monitoring solutions for telehealth, complete with smartphone applications, and produces COVID-19 antigen rapid test kits. Complementing its product portfolio, the company offers essential services in areas like regulatory guidance, clinical recommendations, engineering support, and manufacturing system development.
www.taidoc.comNo one on the platform currently holds 4736.TWO.
No tracked institution reports a position in 4736.TWO as of their last filing.
No one on the platform has traded 4736.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 4 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-11-07 | $1.95 | $3.43 | +75.9% |
| 2023-08-08 | $2.26 | $1.82 | -19.5% |
| 2023-05-09 | $3.75 | $4.17 | +11.2% |
| 2023-03-07 | $5.97 | $4.08 | -31.7% |
| 2022-11-01 | $7.38 | $8.31 | +12.6% |
| 2022-08-02 | $17.03 | $16.32 | -4.2% |
| 2022-05-14 | $4.30 | $6.50 | +51.2% |
| $82.50 |
| -0.12% |
| $8.0B |
| — |
| 4162.TWOPharmaEngine, Inc. | $54.70 | -0.18% | $7.9B | — |
| 4771.TWVizionfocus Inc. | $206.50 | -1.90% | $12.1B | — |
Source: Financial Modeling Prep · peers by sector/industry